RBC Capital raised the firm’s price target on Bausch + Lomb (BLCO) to $19 from $17 and keeps an Outperform rating on the shares. The company’s Investor Day highlighted the significant operating leverage within the business, while the management also emphasized its robust pipeline, pointing to a steady stream of product launches over the next decade and an estimated peak sales potential of $7B, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Cautious Hold Rating on Bausch + Lomb: Awaiting Catalysts for Stock Valuation Boost
- Cautious Outlook on Bausch + Lomb: Sell Rating Amid Optimistic Projections and Execution Risks
- Bausch + Lomb Unveils Strategic Growth Plan at Investor Day
- Bausch + Lomb backs FY25 revenue view $5.050B-$5.150B, consensus $5.08B
- Bausch + Lomb provides three-year plan at investor day
